Verdence Capital Advisors LLC Cerus Corp Transaction History

Verdence Capital Advisors LLC

  • $1.23 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022
BUY
$3.43 - $5.83 $2,764 - $4,698
806 Added 3.58%
23,319 $84,000
Q2 2022

Aug 08, 2022
BUY
$4.41 - $5.69 $40,836 - $52,689
9,260 Added 69.87%
22,513 $119,000
Q1 2022

May 02, 2022
BUY
$4.81 - $6.99 $5,978 - $8,688
1,243 Added 10.35%
13,253 $73,000
Q4 2021

Jan 26, 2022
BUY
$5.97 - $7.93 $71,699 - $95,239
12,010 New
12,010 $82,000

Others Institutions Holding CERS

# of Institutions
156
Shares Held
147M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Verdence Capital Advisors LLC Portfolio

Follow Verdence Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email